Voriconazole
Voriconazole is a pharmaceutical drug with 83 clinical trials. Historical success rate of 82.2%.
Success Metrics
Based on 60 completed trials
Phase Distribution
Phase Distribution
22
Early Stage
10
Mid Stage
35
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
60 of 75 finished
20.0%
15 ended early
0
trials recruiting
83
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
Study on the Drug Interaction Between Buagafuran and Voriconazole
Effect of Dexamethasone on CYP Enzyme Activity in Healthy Male Subjects
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants
Clinical Trials (83)
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
Study on the Drug Interaction Between Buagafuran and Voriconazole
Effect of Dexamethasone on CYP Enzyme Activity in Healthy Male Subjects
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants
Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
Registry of Patients Treated With Systemic Mold-Active Triazoles
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis
Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 83